| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $22.29M | $32.61M | $37.06M | $50.19M | $37.48M |
| R&D | – | – | – | – | – |
| SG&A | $11.33M | $13.04M | $18.77M | $19.80M | $15.82M |
| Operating Income | -$22.29M | -$32.61M | -$37.06M | -$50.19M | -$37.48M |
| Interest Expense | $32.00K | $90.00K | $144.00K | $219.00K | $670.00K |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$21.09M | -$30.16M | -$34.10M | -$48.59M | -$36.79M |
| EPS (basic) | -16.7200 | -1.2000 | -1.2200 | -1.5800 | -1.3300 |
| EPS (diluted) | -16.7200 | -1.2000 | -1.2200 | -1.5800 | -1.3300 |
| Shares (diluted) | $1.26M | $25.12M | $27.95M | $30.70M | $27.71M |